$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Endocrinology
Endocrinology
日本武田的曲格列汀在中国批准上市了吗?
2025-10-19 11:44:20
Check Details
日本武田的曲格列汀什么时候服用效果好?
2025-10-19 11:44:20
Check Details
阿斯利康降糖药达格列净哪里能买到
2025-10-19 11:44:20
Check Details
日本武田的曲格列汀在国内买的到吗?
2025-10-19 11:44:20
Check Details
阿斯利康降糖药达格列净纳入医保了吗
2025-10-19 11:44:20
Check Details
日本武田的曲格列汀疗效怎么样?
2025-10-19 11:44:20
Check Details
阿斯利康降糖药达格列净如何购买
2025-10-19 11:44:20
Check Details
日本武田的曲格列汀适用于什么病症?
2025-10-19 11:44:20
Check Details
阿斯利康降糖药达格列净使用说明
2025-10-19 11:44:20
Check Details
阿斯利康降糖药达格列净是一种什么药物呢
2025-10-19 11:44:20
Check Details
阿斯利康降糖药达格列净的适应症
2025-10-19 11:44:20
Check Details
阿斯利康降糖药达格列净适应症有哪些
2025-10-19 11:44:20
Check Details
1
2
...
226
227
228
229
230
231
232
...
293
294
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Trelagliptin Once-Weekly DPP-4 for Type 2 Diabetes: Dosing, Renal Adjustment, Discontinuation
2
Orforglipron (Foundayo) vs Metformin: Oral GLP-1 Weight Loss and T2D Use
3
Trelagliptin: A Once-Weekly Long-Acting Oral DPP-4 Inhibitor
4
Oral Semaglutide Tablets: A Complete Guide to the GLP-1 Receptor Agonist for Type 2 Diabetes and Cardiovascular Protection
5
Cabergoline Medication Guide: Contraindications, Treatment Costs, and Safety Monitoring Essentials
6
Cabergoline Explained: Mechanism, Four Key Warnings & Dosing Guide
7
Orforglipron: The World's First Oral Small-Molecule GLP-1 Receptor Agonist for Weight Management
8
Mirogabalin Discontinuation Guide: Safe Tapering and Key Considerations
9
Mechanism and Clinical Value of Pemafibrate in Triglyceride Lowering
10
Metyrapone Guide: Diagnostic Testing for Adrenal Insufficiency
11
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
12
Loargys(Pegzilarginase-nbln) Complete Medication Guide: Pre-Treatment Assessment, Monitoring and Home Administration